Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS approval · 2019-02-04

Clinical Trial Update: Emergency/Compassionate Use - Muscular VSD Occluder

View source ↗

Summary

Abbott Medical Devices' Muscular VSD Occluder has been approved for marketing to treat muscular ventricular septal defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Muscular VSD Occluder

Snippet

Sponsor: Abbott Medical Devices | Conditions: Muscular, Ventricular | Status: APPROVED_FOR_MARKETING